Cita APA

Garey, K. W., Garey, K. W., Kankam, M., Mercier, J., Seng Yue, C., Ducharme, M., . . . Silverman, M. (2019). LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor. Open Forum Infect Dis.

Chicago Style Citation

Garey, Kevin W., et al. "LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor." Open Forum Infect Dis 2019.

Cita MLA

Garey, Kevin W., et al. "LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor." Open Forum Infect Dis 2019.